prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, FINAL DIAGNOSIS: PART 1: BREAST, RIGHT, NEEDLE LOCALIZED SEGMENTAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA, 1.9 CM (GROSS), NOTTINGHAM GRADE 2 (COMBINED NOTTINGHAM. SCORE 6/9: TUBULE FORMATION 3/3, NUCLEAR ATYPIA 2/3, MITOTIC ACTIVITY 1/3). B. DUCTAL CARCINOMA IN SITU, EXTENSIVE, SOLID TYPE NUCLEAR GRADE 2, WITH LOBULAR. CANCERIZATION AND FOCAL COMEDO TYPE NECROSIS, ASSOCIATED WITH INVASIVE TUMOR AND. COMPRISES MORE THAN 25% OF TUMOR VOLUME. C. LYMPHOVASCULAR INVASION IS IDENTIFIED. D. MARGINS FREE, CLOSEST ANTERIOR WITHIN 0.4 CM, SECOND CLOSEST POSTERIOR WITHIN 0.5 CM. E. SCLEROSING ADENOSIS. F. FIBROADENOMATOID CHANGES. G. BIOPSY SITE CHANGES. H. PATHOLOGIC STAGE (see comment). PART 2: SENTINEL LYMPH NODE NUMBER 1, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART 3: SENTINEL LYMPH NODE NUMBER 2, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: Maximum dimension invasive component: 1.9 cm. TUMOR TYPE (invasive component): NOTTINGHAM SCORE: Ductal adenocarcinoma, NOS. Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 6. ANGIOLYMPHATIC INVASION: Nottingham grade (1, 2, 3): 2. DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: TUMOR TYPE, IN SITU: Solid. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Percent of tumor occupied by in situ component: 35 %. SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 2. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. T STAGE, PATHOLOGIC: pT1c. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: 2+.

expanded version (tokens=1095) : 
 Here is the expanded information from the breast pathology report:

1. Histological Classification:
a) Invasive ductal carcinoma
b) Ductal carcinoma in situ, extensive, solid type nuclear grade 2, with lobular cancerization and focal comedo type necrosis
c) Subtype LumA

2. Histological Grade:
a) Nottingham grade 2
b) Nuclear grade 2
c) Tubule formation score: 3/3
d) Nuclear atypia score: 2/3
e) Mitotic activity score: 1/3
f) Total Nottingham score: 6/9

3. Lymphovascular Invasion: Identified.

4. Calcification: Not applicable.

5. Ancillary Testing Results:
a) Receptor Status: Estrogen receptors are positive and Progesterone receptors are positive.
b) HER2/NEU: Score 2+.

6. Other Ancillary Testing:
a) Surgical margins free, closest anterior within 0.4 cm, second closest posterior within 0.5 cm
b) One lymph node, negative for metastatic carcinoma (0/1)
c) Percent of tumor occupied by in situ component: 35%
d) lymph nodes examined: 2
e) Method(s) of lymph node examination: H/E stain
f) Pathologic stage: pT1c. pNO, pMX.

Overall, the report confirmed the presence of invasive

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1255) : 
 The breast pathology report shows invasive ductal carcinoma with extensive solid nuclear grade 2 ductal carcinoma in situ. The tumor is LumA subtype, with identified lymphovascular invasion and negative lymph nodes for metastatic carcinoma. Estrogen and progesterone receptors are positive, while HER2/NEU is scored as 2+. Nottingham grade 2 for the tumor's histological grade is reported, with a total score of 6/9. Surgical margins are free, and the pathologic stage is pT1c, pNO, pMX.

